|
Program Objective: This program promotes teaching and research
on issues related to pharmaceuticals and the pharmaceutical
industry. It trains professionals seeking careers in the area,
and supports the work of industry and government.
Director:
William
S. Comanor
Associate Directors:
Stuart O. Schweitzer
Michael O. Intriligator
Telephone : (310)
206-1641
Fax: (310) 825-3317
Current Schedule:
UCLA School of Public
Health
Department of Health Services
2007 - 2008
SEMINAR ON PHARMACEUTICAL ECONOMICS AND POLICY
1. October 4, 2007
Stuart O. Schweitzer
UCLA
Title: "The Impact of Genetic Testing on the Pharmaceutical
Industry"
2. October 18, 2007
William S. Comanor
UCLA and UCSB
Title: “An Introduction to the Economics of the Pharmaceutical
Industry”
3. November 1, 2007
Kim Jinnett
Integrated Benefits Institute, San Francisco
Title: “A Broader Reach to Pharmacy Plan Design”
4. December 6, 2007
Ben Zycher
Manhattan Institute for Policy Research
Title: “The Human Cost of Federal Price Negotiations:
the Medicare Prescription Drug Benefit and Pharmaceutical Innovation”
5. January 17, 2008
Joel Hay
University of Southern California
Title: "How to Measure Drug Costs in Cost-effectiveness
Analysis?"
6. February
7, 2008
Ariel Katz
University of Toronto, Canada
Title: "Pharmaceutical Lemons: Innovation and Regulation
in the Drug Industry”
7. February 28, 2008
Randall Lutter
Deputy Commissioner for Policy, FDA
Title: “Managing Conflict of Interest Issues among FDA
Advisors”
8. April
10, 2008
David Levine
Washington University in St. Louis
Title: “Patents and Monopoly in Pharmaceuticals”
9. April
24, 2008
Richard Frank
Harvard University
Title: “Rethinking FDA Regulation of Biologics "
10. May 8, 2008
Joshua
Ofman
AMGEN
Title: “Evolving Policies towards the Biotechnology Industry”
All meetings are
held in the Dean's Conference Room 16-059 CHS at the UCLA School
of Public Health on Thursday afternoons from 4:30 PM - 6:30
PM. There will be dinner with the speaker at the UCLA Faculty
Center following the Seminar.
PDF version here.
Past
Schedules:
UCLA School of Public
Health
Department of Health Services
2006 - 2007
1.
October 12, 2006
William S. Comanor
UCLA and UCSB
Title: "An Introduction to the Economics of the Pharmaceutical
Industry"
2.
October 19, 2006
Gerard Viens
ESSEC, Paris
Title:
"Pharmaceutical economics and pricing policy in France"
3. November 16, 2006
Iain Cockburn
Boston University and NBER
Title: "Is the Pharmaceutical Industry in a Productivity
Crisis?"
4. November 30, 2006
Darren Filson
Claremont Graduate University
Title: "The Impacts of Price Controls on the Performance
of the Research-Based Pharmaceutical Industry"
5. January 25, 2007
Jerome Hoffman
School of Medicine, UCLA
Title: “Industry Sponsored Clinical Research – Is
it Possible to Restore Trust?”
6.
February 8, 2007
Jason Doctor
USC
Title: “Should Health Insurers Fund Life-style Drugs?”
7.
March 8, 2007
David Meltzer
University of Chicago
Title: "The Institute of Medicine Report on Drug Safety
and the FDA.”
8.
April 26, 2007
Jennifer
Malin
Amgen
Title:
“Cost Effectivelness Analysis and Public Policy”
9.
May 17, 2007
Scott Hemphill
Columbia University
Title:
“Paying for Delay: Pharmaceutical Patent Settlement as
a Regulatory Design Problem”
10.
May 31, 2007
Geoffrey
Joyce
RAND
Title: "The Implications of Government Imposed
Drug Discounts"
UCLA School of Public
Health
Department of Health Services
2005– 2006
1. October 6, 2005
William S. Comanor
UCLA and UCSB
Title: "An
Introduction to the Economics of the Pharmaceutical Industry"
2. November
3, 2005
Stephen
Marder
UCLA
Title: "Academic, Industry, and Government Collaboration
in Drug Development"
3. November
10, 2005
Alan Garber
Stanford University
Title: "Barriers
to Health Care Productivity"
4. December
1, 2005
John Rizzo
State University of New York, Stoneybrook
Title: "Generic
Scrip Share and the Price of Brand Name Drugs”
5. January
19, 2006
Michael Nichol
USC
Title: "Patient
Compliance with Pharmaceuticals as a Predictor of Health Care
Costs”
6. February
16, 2006
Jack Needleman
UCLA
Title: “The
Off-Label Use of Pharmaceuticals: Conflicting Incentives for
Physicians and Drug Companies”
7. March
2, 2006
Thomas Abbott
Medstat Corporation
Title: “The
Cost of US Pharmaceutical Price Reductions: a Financial Simulation
Model of R&D Decisions”
8. April
27, 2006
Darius Lakdawalla
RAND Corporation
Title: "Intellectual
Property and Marketing"
9. May 18,
2006
Alan Mathios
Cornell University
Title: “The
Impact of DTC Advertising on the Demand for Pharmaceuticals:
the cases of smoking cessation and cholesterol reducing drugs”
10. June
1, 2006
Dean Jamison
University of California, San Francisco
Title: “A Friendly
Review of STRONG MEDICINE by Michael Kramer and
Rachael Glennerster”
2004 – 2005
SEMINAR ON PHARMACEUTICAL ECONOMICS AND POLICY
1. October 7, 2004
William S. Comanor
UCLA and UCSB
Title: “An Introduction to the Economics of the Pharmaceutical
Industry”
2. October 28, 2004
Jeffrey McCombs
University of Southern California
Title: “Impact of an Open Access Formulary Policy on
Patients with Schizophrenia”
3. November 18, 2004
Arleen Leibowitz
UCLA
Title: “The California AIDS Drug Assistance Program:
Becoming a Smart Purchaser.”
4. December 2, 2004
Michael Kades
Federal Trade Commission
Title: “FTC Policy Towards Patent Settlements in the
Pharmaceutical Industry.”
5. January 20, 2005
Richard Epstein
University of Chicago
Title: “Is there a Biomedical Anti-commons?”
6. February 17, 2005
FM. Scherer
Harvard and Princeton Universities
Title: “An Economic Perspective on the Influenza Vaccine
Shortage”
7. March 17, 2005
Peter Zweifel
University of Zurich
Title: “Measuring Willingness-to-accept-cuts in Health
Insurance Benefits, including Pharmaceuticals”
8. April 7, 2005
Aidan Hollis
University of Calgary, Canada
Title: “An Efficient Reward System for Pharmaceutical
Innovation”
9. April 28, 2005
Robert M. Kaplan
UCLA
Title: “Pharmaceutical Cost implications of Changing
Diagnostic Thresholds”
10. May 19, 2005
Frank Lichtenberg
Columbia University
Title: “The Expanding Pharmaceutical Arsenal in the War
on Cancer”
UCLA School of Public Health
Department of Health Services
2003 - 2004
SEMINAR ON PHARMACEUTICAL ECONOMICS AND POLICY
--------------------------------------------------------------------------------
1. October 3, 2003
William S. Comanor
UCLA and UCSB
Title: "An Introduction to the Economics of the Pharmaceutical
Industry"
2. October 30, 2003
Frank Sloan
Duke University
Title: "Financing Vaccines in the Twenty-first Century:
Report of the Institute of Medicine, National Academy of Sciences."
3. November 13, 2003
Arthur DeVany
University of California, Irvine
Title: "Blockbusters and Me-too Drugs: Implications for
the Pharmaceutical Industry"
4. December 4, 2003
Joel Hay
University of Southern California
Title: "Claritin's Shift to OTC Status: A Lesson for the
HMO's"
5. January 22, 2004
Christopher Snyder
George Washington University and University of Chicago
Title: "Why are Drugs more Profitable than Vaccines?"
6. February 19, 2004
John E. Calfee
American Enterprise Institute
Title: "The Importation of Pharmaceuticals: Issues for
Public Policy"
7. February 27, 2004
Mary K. Olson
Yale University
Title: "Are Novel Drugs More Risky Than Less Novel Drugs?"
8. March 18, 2004
Stuart O. Schweitzer
UCLA
Title: "The Manufacture and Distribution of Pharmaceuticals
in China."
9. April 8, 2004
Dean Jamison
National Institutes of Health
Title: "Costs and Benefits of Drug and Vaccine Development
for the Poor in Developing Countries"
10. April 29, 2004
Tom Rice
UCLA
Title: "The New Prescription Drug Benefit in Medicare:
Questions for Research and Public Policy"
--------------------------------------------------------------------------------
All meetings are held in the Dean's Conference Room 16-059
CHS at the UCLA School of Public Health on Thursday afternoons
from 4:30 PM - 6:30 PM. There will be dinner with the speaker
at the UCLA Faculty Center following the Seminar.
UCLA School of Public Health
Department of Health Services
2002 - 2003
SEMINAR ON PHARMACEUTICAL ECONOMICS AND POLICY
--------------------------------------------------------------------------------
1. October 3, 2002
William S. Comanor
UCLA and UCSB
Title: "An Introduction to the Economics of the Pharmaceutical
Industry"
2. October 24, 2002
Dana Goldman
RAND Corporation
Title: "The Costs of a Medicare Prescription Drug Benefit"
3. November 7, 2002 Barbara DeBuono
Pfizer Pharmaceuticals
Title: "A Public Health Response to Supplemental Medicaid
Rebates for Pharmaceuticals: the Pfizer Program"
4. December 5, 2002
David Reiffen
U.S. Department of the Treasury
Title: "Generic Drug Industry Dynamics"
5. January 16, 2003
Dominick Esposito
UCSB
Title: "You Get What You Co-Pay for: the Impact of Co-Payments
on the Demand for Pharmaceuticals"
6. January 30, 2003
F.M. Scherer
Harvard and Princeton Universities
Title: "The Supply of Pharmaceuticals to Less Developed
Countries"
7. February 27, 2003
Gian Pietro Leoni
Farmindustria, Italy
Title: "Pharmaceutical Policy Issues in Europe"
8. March 13, 2003
Mark Pauly
University of Pennsylvania
Title: "Prescription Drug Insurance"
9. May 15, 2003
Catherine Wolfram
UC Berkeley
Title: "Pharmaceutical Prices and Political Activity"
10. May 29, 2003
H. E. Frech
UCSB
Title: "Is the United States an Outlier in Health Care
and Health Status?"
--------------------------------------------------------------------------------
All meetings are held in the Dean's Conference Room 16-059
CHS at the UCLA School of Public Health on Thursday afternoons
from 4:30 PM - 6:30 PM. There will be dinner with the speaker
at the UCLA Faculty Center following the Seminar.
2001-2002 SCHEDULE
1. October 4, 2001
William S. Comanor
UCLA and UCSB
Title: "An Introduction to the Economics of the Pharmaceutical
Industry"
2. October 11, 2001
Henry G. Grabowski
Duke University
Title: "New Work on Returns to Research and Development
in the
Pharmaceutical Industry"
3. November 8, 2001
Barbara DeBuono
Pfizer Pharmaceuticals
Title: "A Public Health Response to Supplemental Medicaid
Rebates for Pharmaceuticals: the Pfizer Program"
4. November 29, 2001
Arleen Leibowitz
UCLA
Title: "The Effect of Government Policies on the Demand
for AIDS Drugs"
5. January 17, 2002
Allen T. Sorensen
UCSD
Title: "Price Dispersion and Heterogeneous Consumer Search
for Retail Prescription Drugs"
6. January 24, 2002
Peter Zweifel
University of Zurich
Title: "New Ways to Measure Willingness to Pay for Prescription
Drugs"
7. February 21, 2002
Stuart O. Schweitzer
UCLA
Title: "Factors Determining the Location of Biotech Clusters"
8. April 25, 2002
Ninez Ponce
UCLA
Title: "The Cost of Discovering New Drugs: A Review of
Past Studies"
9. TBA
10. TBA
2000-2001 SCHEDULE
1. October 5, 2000
William S. Comanor
UCLA and UCSB
Title: "An Introduction to the Economics of the Pharmaceutical
Industry"
2. October 19, 2000
Stuart O. Schweitzer
UCLA
Title: “Pharmaceutical Prices and Expenditures”
3. November 16, 2000
Joel Hay
University of Southern California
Title: “Retail Pharmacy Price Variation”
4. November 30, 2000
Toshi Iizuka
UCLA
Title: “The Relationship between Physicians and Patients:
A Study the Prescription Drug Market in Japan”
5. January 11, 2001
Robert Kemp
Aventis Pharma
Title: “Free Market Prescription for the Pharmaceutical
Industry: a 20 Year Perspective”
6. March 1, 2001
Anna Cook
Mathematica Policy Research
Title: “Why Do Different Purchasers Pay Different Prices
for Prescription Drugs?”
7. March 15, 2001
William S. Comanor
UCLA and UCSB
Title: "An Examination of Recent Mergers in the Pharmaceutical
Industry"
8. April 19, 2001
Richard Feachem
UCSF
Title: “Creating Global Markets for Neglected Drugs and
Vaccines: A Challenge for Public-Private Partnership"
9. May 17, 2001
Henry G. Grabowski
Duke University
Title: "New Work on Returns to R and D in the Pharmaceutical
Industry”
10. May 31, 2001
Frank Lichtenberg
Columbia University
Title: “Creative vs. Uncreative Destruction in the US
Pharmaceutical Industry”
1999-2000 SCHEDULE
1. October 7, 1999
William S. Comanor
UCLA and UCSB
Title: "An Introduction to the Economics of the Pharmaceutical
Industry"
2. October 21, 1999
Stuart O. Schweitzer
UCLA
Title: “An Analysis of Formularies under Managed Care”
3. November 18, 1999
Scott Stern
MIT
Title: "The Tension between Basic and Applied Research
in Drug Discovery"
4. December 2, 1999
Gordon Liu
University of Southern California
Title: "Economic Assessment of Substance Abuse Intervention
Programs"
5. January 13, 2000
Iain Cockburn
Boston University
Title: "Hedonic Analysis of Arthritis Drugs"
6. January 27, 2000
Michael D. Intriligator
UCLA
Title: "The Economics of the Brand Name Prescription Drug
Antitrust Case"
7. March 2, 2000
William Hausdorff
Wyeth Lederle Vaccines
Title: "The Joint Supply of Vaccines for Developed and
Less Developed Countries"
8. May 4, 2000
Jenny Lanjouw
Yale University
Title: "The Introduction of Pharmaceutical Product Patents
in India"
9. May 25, 2000
Z. John Lu
Amgen, Inc.
Title: "Impact of Disease and Treatment on Quality of
Life from Secondary Hyperparathyroidism in Patients with Renal
Failure"
10. TBA
All meetings are held in the Dean's Conference Room 16-059
CHS at the UCLA School of Public Health on Thursday afternoons
from 4:30 PM - 6:30 PM. There will be dinner with the speaker
at the UCLA Faculty Center following the Seminar.
1998-1999 SCHEDULE
1. October 8, 1998
William S. Comanor
UCLA and UCSB
Title: "An Introduction to the Economics of the Pharmaceutical
Industry"
2. October 29, 1998
Didier Sornette
Universite de Nice - Sophia Antipolis, France
Title: "Economic Returns of Pharmaceutical Research"
3. November 12, 1998
Rika Mortimer
U.S. Department of Justice
Title: "Demand for Prescription Drugs: the Effects of
Managed
Care Pharmacy Benefits"
4. December 3, 1998
D. Larry Smith
Sutro & Company
Title: "The Pharmaceutical Industry from a Security Analysis
Perspective"
5. January 21, 1999
Michael Woolley
Amgen, Inc.
Title: "An Economic Model of Pharmaceutical Treatments
for
ALS"
6. February 11, 1999
Ernst Berndt
Massachusetts Institute of Technology
Title: "The Course and Cost of the Treatment of Depression
with
Alternate Drugs"
7. March 11, 1999
Alison Keith
Pfizer Pharmaceuticals
Title: "The Economics of Viagra"
8. April 8, 1999
David Evans
World Health Organization, Geneva
Title: "The Economics of New Anti-Malarial Drugs and Vaccines"
9. April 22, 1999
Marvin Lieberman
UCLA
Title: "Geographic Organization and Technological Innovation
in
the US Pharmaceutical Industry"
10. May 6, 1999
Tanja Carter
UCSB
Title: "A Hedonic Model of Drug Pricing"
1997-1998 SCHEDULE
1. October 9, 1997
William S. Comanor
UCLA and UCSB
Title: "An Introduction to the Economics of the Pharmaceutical
Industry"
2. October 23, 1997
Scott Stern
Massachusetts Institute of Technology
Title: "The Empirical Implications of Physician Authority
in Pharmaceutical Decision-making"
3. November 20, 1997
M. Haim Erder
Amgen, Inc.
Title: "Willingness to Pay to Avoid Febrile Neutropenia"
4. December 4, 1997
David J. Ravenscraft
University of North Carolina
Title: "Paths to Creating Value in Pharmaceutical Mergers"
5. January 15, 1998
Ronald M. Andersen
UCLA
Title: "The Use of Pharmaceuticals by the Treated HIV
Population in the United States"
6. February 5, 1998
Sam Ho
Pacificare Health System
and
Paul Torrens
UCLA
Title: "Managing Pharmacy Costs from a Managed Care Perspective"
7. February 26, 1998
Takeo Nakao
Doshisha University, Japan
Title: "The Determinants of Profit Rates in Japanese Pharmaceutical
Firms"
8. April 9, 1998
Fiona Scott Morton
University of Chicago
Title: "The Objectives of the FDA's Office of Generic
Drugs"
9. April 23, 1998
Kathy Johnson
USC
Title: "The Impact of Pharmacists on the Demand for Pharmaceuticals"
10. June 4, 1998
Douglas Cocks
Eli Lilly & Co
Title: "Is Drug Price Inflation Different for the Elderly?"
|
